Michael Francis Mccagh, MD | |
100 Welton Drive, Cumberland, MD 21502-1336 | |
(301) 777-7900 | |
(301) 777-5381 |
Full Name | Michael Francis Mccagh |
---|---|
Gender | Male |
Speciality | Dermatology |
Location | 100 Welton Drive, Cumberland, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225021827 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | D0019076 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Michael Francis Mccagh, MD 100 Welton Drive, Cumberland, MD 21502-1336 Ph: (301) 777-7900 | Michael Francis Mccagh, MD 100 Welton Drive, Cumberland, MD 21502-1336 Ph: (301) 777-7900 |
News Archive
New research presents strong evidence that the Zika virus can indeed cause a range of abnormalities in pregnant women infected with the virus - with the effects manifesting any time during pregnancy. Some of the abnormalities noted have not been reported in connection with the virus.
New research indicates that a diagnostic strategy using computed tomographic pulmonary angiography (CTPA) may be a safe alternative to conventional lungs scans (known as ventilation-perfusion scans) for excluding the diagnosis of pulmonary embolism (blood clots in the lung vessels), although CTPA may detect more clots, according to a study in the current issue of JAMA: The Journal of the American Medical Association.
The Pentagon needs to overhaul its approach to treating the tens of thousands of U.S. troops who might have traumatic brain injury, the most common injury of the Iraq war, according to a previously undisclosed Department of Defense memorandum obtained by USA Today.
Scientists from the National Institute of Allergy and Infectious Diseases, the National Institute of Dental and Craniofacial Research, and the National Heart, Lung and Blood Institute all parts of the National Institutes of Health, describe how combining engineered anthrax toxin proteins and existing chemotherapy drugs could potentially yield a therapy to reduce or eliminate cancerous tumors.
Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.
› Verified 5 days ago
Dr. Kenrick Hamilton Roberts, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 100 Welton Dr, Cumberland, MD 21502 Phone: 301-777-7900 Fax: 301-777-5381 | |
Daniel Herring, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 100 Welton Dr, Cumberland, MD 21502 Phone: 301-777-5306 Fax: 301-777-5381 | |
Patrick Joseph Brown, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 100 Welton Dr, Cumberland, MD 21502 Phone: 301-777-7900 Fax: 301-724-5590 |